Canakinumab Subcutaneous and Topiramate ER Capsules
Determining the interaction of Canakinumab Subcutaneous and Topiramate ER Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: topiramate
Brand name: Qudexy XR Sprinkle, Topamax, Topamax Sprinkle, Trokendi XR, Topiragen, Qudexy XR
Synonyms: Topiramate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Topiramate Extended-Release Capsules
- Canakinumab Subcutaneous-Topiramate Extended-Release Sprinkle Capsules
- Canakinumab Subcutaneous-Topiramate Sprinkle Capsules
- Canakinumab Subcutaneous-Topiramate Tablets
- Canakinumab Subcutaneous-Topisulf Cream
- Canakinumab Subcutaneous-Toposar
- Topiramate ER Capsules-Canasa
- Topiramate ER Capsules-Canasa Pac rectal
- Topiramate ER Capsules-Canasa rectal
- Topiramate ER Capsules-Cancidas
- Topiramate ER Capsules-Candesartan
- Topiramate ER Capsules-Candesartan and Hydrochlorothiazide